PDL BioPharma, Inc. Long-Lived Assets
PDL BioPharma, Inc. had Long-Lived Assets of $5.99 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2021-03-29
- 2020-06-30: Long-Lived Assets $5.99M.
- 2020-03-31: Long-Lived Assets $6.17M.
- 2019-12-31: Long-Lived Assets $5.52M.
- 2019-09-30: Long-Lived Assets $6.58M.
| Period end | Long-Lived Assets |
|---|---|
| 2020-06-30 | $5.99M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $6.17M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.52M 10-K · filed 2021-03-29 |
| 2019-09-30 | $6.58M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.91M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $7.39M 8-K · filed 2020-06-29 |
| 2018-09-30 | $8.84M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $9.22M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $7.56M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $7.22M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $8.13M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.20M 10-Q · filed 2017-08-03 |
| 2016-12-31 | $38.00K 10-Q · filed 2017-11-13 |
| 2015-12-31 | $31.00K 10-K · filed 2017-03-01 |